Philogen announces its attendance at the European Bispecific and Multispecific Antibody congress in Amsterdam.
Dr. Roberto De Luca (Head of Antibody Therapeutics at Philochem) is giving a lecture on the 23rd of February 2023 entitled “Engineering Antibody-Cytokine Fusion proteins for Cancer Therapy”.
Please follow the link below for more information
https://multispecificseu.com/events/european-bispecific-multispecific-antibody-congress#
https://multispecificseu.com/events/european-bispecific-multispecific-antibody-congress#